Bright's disease today: the pathogenesis and treatment of glomerulonephritis. 3.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000906:Antibodies; D000941:Antigens; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases; D003165:Complement System Proteins; D003345:Corticosterone / Q000627:therapeutic use; D005337:Fibrin / Q000096:biosynthesis; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D006801:Humans; D051379:Mice; D008814:Mice, Inbred NZB; D008815:Mice, Inbred Strains; D009393:Nephritis; D010965:Plasmodium malariae / Q000472:pathogenicity; D012376:Rodent Diseases
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D000941:Antigens; D000970:Antineoplastic Agents; D005337:Fibrin; D003165:Complement System Proteins; D003345:Corticosterone